Trademark: 97930680
Word
AUTOTAC
Status
Pending
Status Code
688
Status Date
Tuesday, April 30, 2024
Serial Number
97930680
Mark Type
4
Filing Date
Wednesday, May 10, 2023
Published for Opposition
Tuesday, March 5, 2024

Trademark Owner History
Frontier Medicines Corporation - Owner At Publication

Classifications
5 Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, neurodegenerative disease, neuropsychiatric disorders, cardiometabolic disease, diseases of the eye, dermatological diseases, pain, monogenic disorders, and hereditary diseases

Trademark Events
Dec 28, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 13, 2023
New Application Entered
Jun 9, 2023
New Application Office Supplied Data Entered
Dec 28, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 28, 2023
Teas Change Of Correspondence Received
Dec 28, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 26, 2024
Approved For Pub - Principal Register
Jan 24, 2024
Assigned To Examiner
Feb 14, 2024
Notification Of Notice Of Publication E-Mailed
Feb 14, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2024
Published For Opposition
Apr 16, 2024
Teas Change Of Correspondence Received
Mar 5, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 16, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 16, 2024
Teas Change Of Owner Address Received
Apr 30, 2024
Noa E-Mailed - Sou Required From Applicant
May 15, 2024
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24